Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an…
WOKING, England, March 13, 2025 /PRNewswire/ -- BioIVT, a leading provider of in vitro ADME research services, has successfully completed…
PITTSBURGH, March 13, 2025 /PRNewswire/ -- Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position…
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today…
Distinguished Biotech, Pharmaceutical and Healthcare Leaders Will Headline Three Days of Inspiring Innovation at the 24th Annual Conference & Expo,…
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce…
Boston (March 13, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated…
NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and…
BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an…
Award established to recognize leaders in the field of chronic kidney disease advocacyWALTHAM, Mass., March 13, 2025 (GLOBE NEWSWIRE) --…